Kinase 
 Inhibition and
Nanotechnology for 
Diabetes
research group

 

​The KIND group was established with the focus to understand the fundamental properties of kinase inhibitors, its effective nano-delivery and stem cell activation to regenerate the damaged pancreas to treat Diabetes.

​

We are located within the X-Ray Crystallography Laboratory at the Malopolska Centre of Biotechnology at the Jagiellonian University in Krakow, Poland.